Home LiteratureArticle Details
PMID: 18796545 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.

American journal of physiology. Endocrinology and metabolism ·Vol. 295 ·No. 5 ·2008-11-00 ·Pages E1160-6

Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ

Abstract

Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are anti-diabetes/obesity hormones secreted from the gut after meal ingestion. We have shown that dietary-resistant starch (RS) increased GLP-1 and PYY secretion, but the mechanism remains unknown. RS is a fermentable fiber that lowers the glycemic index of the diet and liberates short-chain fatty acids (SCFAs) through fermentation in the gut. This study investigates the two possible mechanisms by which RS stimulates GLP-1 and PYY secretion: the effect of a meal or glycemic index, and the effect of fermentation. Because GLP-1 and PYY secretions are stimulated by nutrient availability in the gut, the timing of blood sample collections could influence the outcome when two diets with different glycemic indexes are compared. Thus we examined GLP-1 and PYY plasma levels at various time points over a 24-h period in RS-fed rats. In addition, we tested proglucagon (a precursor to GLP-1) and PYY gene expression patterns in specific areas of the gut of RS-fed rats and in an enteroendocrine cell line following exposure to SCFAs in vitro. Our findings are as follows. 1) RS stimulates GLP-1 and PYY secretion in a substantial day-long manner, independent of meal effect or changes in dietary glycemia. 2) Fermentation and the liberation of SCFAs in the lower gut are associated with increased proglucagon and PYY gene expression. 3) Glucose tolerance, an indicator of increased active forms of GLP-1 and PYY, was improved in RS-fed diabetic mice. We conclude that fermentation of RS is most likely the primary mechanism for increased endogenous secretions of total GLP-1 and PYY in rodents. Thus any factor that affects fermentation should be considered when dietary fermentable fiber is used to stimulate GLP-1 and PYY secretion.

MeSH Terms
Adipose Tissue/drug effects,metabolism Animals Blood Glucose/metabolism Cell Line Cholecystokinin/genetics Dietary Carbohydrates/administration & dosage,metabolism,pharmacology Dipeptidyl Peptidase 4/blood Eating/drug effects Female Fermentation Gastric Mucosa/metabolism Gene Expression/drug effects Ghrelin/genetics Glucagon-Like Peptide 1/blood Humans Insulin/blood Intestinal Mucosa/metabolism Intestines/drug effects Male Mice Mice, Inbred C57BL Peptide YY/blood,genetics Proglucagon/genetics Rats Rats, Sprague-Dawley Starch/administration & dosage,metabolism,pharmacology Stomach/drug effects
Chemicals
Blood Glucose Dietary Carbohydrates Ghrelin Insulin Peptide YY Proglucagon Glucagon-Like Peptide 1 Starch Cholecystokinin Dipeptidyl Peptidase 4
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Zhou June
Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA. zhouj@pbrc.edu
Martin Roy J
Tulley Richard T
Raggio Anne M
McCutcheon Kathleen L
Shen Li
Danna Samuel Colby
Tripathy Sasmita
Hegsted Maren
Keenan Michael J
References (43)
43 references, click to expand
  1. Guar gum consumption in adolescent and adult rats: short- and long-term metabolic effects.
    Can J Physiol Pharmacol. 1985 Sep;63(9):1113-21 PMID: 2413977
  2. Increased atherosclerosis in streptozotocin-induced diabetic mice.
    J Clin Invest. 1996 Apr 1;97(7):1767-73 PMID: 8601643
  3. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut.
    Obesity (Silver Spring). 2006 Apr;14(4):683-9 PMID: 16741270
  4. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat.
    Int J Obes (Lond). 2006 Feb;30(2):288-92 PMID: 16231018
  5. The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.
    Expert Opin Investig Drugs. 2005 May;14(5):647-53 PMID: 15926870
  6. Resistant starches and health.
    J AOAC Int. 2004 May-Jun;87(3):769-74 PMID: 15287678
  7. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.
    Biochemistry. 2001 Mar 6;40(9):2860-9 PMID: 11258897
  8. Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety.
    Br J Nutr. 2006 Nov;96(5):795-8 PMID: 17092365
  9. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data.
    J Nutr. 2007 Nov;137(11 Suppl):2547S-2551S PMID: 17951500
  10. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6874-9 PMID: 10823914
  11. Impact of inulin and oligofructose on gastrointestinal peptides.
    Br J Nutr. 2005 Apr;93 Suppl 1:S157-61 PMID: 15877889
  12. Effects of PYY[3-36] in rodent models of diabetes and obesity.
    Int J Obes Relat Metab Disord. 2004 Aug;28(8):963-71 PMID: 15197409
  13. Fourteen weeks of treatment with Viscofiber increased fasting levels of glucagon-like peptide-1 and peptide-YY.
    J Med Food. 2007 Dec;10(4):720-4 PMID: 18158848
  14. Incretin-based therapies: mimetics versus protease inhibitors.
    Trends Endocrinol Metab. 2007 Aug;18(6):240-5 PMID: 17629492
  15. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats.
    J Anim Sci. 1997 Sep;75(9):2453-62 PMID: 9303464
  16. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet.
    J Nutr. 1993 Nov;123(11):1939-51 PMID: 8229312
  17. Dietary fibre, glycaemic response, and diabetes.
    Mol Nutr Food Res. 2005 Jun;49(6):560-70 PMID: 15926145
  18. The biology of incretin hormones.
    Cell Metab. 2006 Mar;3(3):153-65 PMID: 16517403
  19. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
    Obes Res. 2005 Jun;13(6):1000-7 PMID: 15976142
  20. Gut peptides in the regulation of food intake and energy homeostasis.
    Endocr Rev. 2006 Dec;27(7):719-27 PMID: 17077190
  21. The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis.
    Ann N Y Acad Sci. 2006 Jul;1070:10-26 PMID: 16888147
  22. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs.
    J Nutr. 1998 Oct;128(10):1786-93 PMID: 9772150
  23. Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans.
    Nutrition. 2005 Oct;21(10):1036-43 PMID: 16157241
  24. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.
    J Clin Endocrinol Metab. 2005 Jan;90(1):359-65 PMID: 15483088
  25. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.
    Brain Res. 2005 May 17;1044(1):127-31 PMID: 15862798
  26. Gut hormones and appetite control.
    Gastroenterology. 2007 May;132(6):2116-30 PMID: 17498507
  27. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat.
    Obesity (Silver Spring). 2006 Sep;14(9):1523-34 PMID: 17030963
  28. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.
    Diabetes. 2006 May;55(5):1484-90 PMID: 16644709
  29. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Clin Ther. 2008 Mar;30(3):513-27 PMID: 18405789
  30. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.
    Br J Nutr. 2004 Sep;92(3):521-6 PMID: 15469657
  31. Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety.
    Am J Clin Nutr. 1994 Oct;60(4):544-51 PMID: 8092089
  32. Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases.
    J Biol Chem. 1993 Aug 15;268(23):17247-52 PMID: 8102366
  33. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.
    Diabetes. 1999 Apr;48(4):706-13 PMID: 10102685
  34. A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults.
    Int J Obes Relat Metab Disord. 2002 Jan;26(1):87-9 PMID: 11791151
  35. Biology of incretins: GLP-1 and GIP.
    Gastroenterology. 2007 May;132(6):2131-57 PMID: 17498508
  36. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
    J Endocrinol. 2005 Jun;185(3):457-65 PMID: 15930172
  37. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
    Endocrinology. 2007 Oct;148(10):4965-73 PMID: 17584962
  38. Rat cecal inocula produce different patterns of short-chain fatty acids than fecal inocula in in vitro fermentations.
    J Nutr. 1995 Oct;125(10):2463-70 PMID: 7562080
  39. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E238-45 PMID: 16940471
  40. Prebiotic digestion and fermentation.
    Am J Clin Nutr. 2001 Feb;73(2 Suppl):415S-420S PMID: 11157351
  41. PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones.
    Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E698-708 PMID: 18285527
  42. Classification and measurement of nutritionally important starch fractions.
    Eur J Clin Nutr. 1992 Oct;46 Suppl 2:S33-50 PMID: 1330528
  43. Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease.
    Nutrition. 1999 Mar;15(3):183-8 PMID: 10198911
Article Info
Journal
American journal of physiology. Endocrinology and metabolism
Abbr.
Am J Physiol Endocrinol Metab
ISSN
0193-1849
Published
2008-11-00
Epub
2008-00-16
Pages
E1160-6
Language
English
Region
United States
NLM ID
100901226
PMCID
PMC2584810
Subset
IM
Grants
NIDDK NIH HHS · P30 DK072476 · United States
NIDDK NIH HHS · R21 DK073403 · United States
NIDDK NIH HHS · R21 DK-073403-01A1 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com